The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...
NHS England has proposed a phased rollout of tirzepatide, a promising weight-loss drug, to benefit patients most likely to ...
While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, ...
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback